HUP9802672A3 - Fused polycyclic pyrimidindione derivatives, process for their preparation and pharmaceutical compositions thereof - Google Patents

Fused polycyclic pyrimidindione derivatives, process for their preparation and pharmaceutical compositions thereof

Info

Publication number
HUP9802672A3
HUP9802672A3 HU9802672A HUP9802672A HUP9802672A3 HU P9802672 A3 HUP9802672 A3 HU P9802672A3 HU 9802672 A HU9802672 A HU 9802672A HU P9802672 A HUP9802672 A HU P9802672A HU P9802672 A3 HUP9802672 A3 HU P9802672A3
Authority
HU
Hungary
Prior art keywords
pyrimidindione
derivatives
preparation
pharmaceutical compositions
fused polycyclic
Prior art date
Application number
HU9802672A
Other languages
English (en)
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of HUP9802672A2 publication Critical patent/HUP9802672A2/hu
Publication of HUP9802672A3 publication Critical patent/HUP9802672A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HU9802672A 1995-05-31 1996-05-31 Fused polycyclic pyrimidindione derivatives, process for their preparation and pharmaceutical compositions thereof HUP9802672A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13399295 1995-05-31
JP30919595 1995-11-28

Publications (2)

Publication Number Publication Date
HUP9802672A2 HUP9802672A2 (hu) 1999-04-28
HUP9802672A3 true HUP9802672A3 (en) 2000-04-28

Family

ID=26468199

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9802672A HUP9802672A3 (en) 1995-05-31 1996-05-31 Fused polycyclic pyrimidindione derivatives, process for their preparation and pharmaceutical compositions thereof

Country Status (12)

Country Link
US (1) US5952335A (hu)
EP (1) EP0831094B1 (hu)
KR (1) KR100399704B1 (hu)
CN (1) CN1067686C (hu)
AT (1) ATE284401T1 (hu)
AU (1) AU703111B2 (hu)
DE (1) DE69634004T2 (hu)
ES (1) ES2229272T3 (hu)
HU (1) HUP9802672A3 (hu)
MX (1) MX9709254A (hu)
NO (1) NO310149B1 (hu)
NZ (1) NZ308657A (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10164564B4 (de) * 2001-12-14 2007-05-16 Zentaris Gmbh Tetrahydrocarbazolderivate als Liganden für G-Protein gekoppelte Rezeptoren (GPCR)
WO2004063156A1 (en) * 2003-01-08 2004-07-29 Biovitrum Ab Novel indole derivates as fabp-4 inhibitors
JP2008501719A (ja) * 2004-06-04 2008-01-24 ケムジェネックス・ファーマシューティカルズ・インコーポレイテッド ナフタルイミドおよびparp−1インヒビターを使用する細胞増殖性疾患の処置方法
WO2010148350A1 (en) * 2009-06-18 2010-12-23 Cornell University Photoproducts of tryptophan, their synthesis and uses thereof
CN104098506A (zh) * 2014-07-15 2014-10-15 华东理工大学 一类苯并[c]咔唑酰胺化合物的制备方法及用途
CN107141295A (zh) * 2017-05-27 2017-09-08 重庆文理学院 一种尿嘧啶类衍生物的简易合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3962438A (en) * 1975-01-07 1976-06-08 Smithkline Corporation Anti-arthritic 1H-pyrimido-(5,4,3-kl)phenothiazine-1,3(2H)-diones and 1-thiones
AU643539B2 (en) * 1990-06-26 1993-11-18 Research Corporation Technologies, Inc. 1,2-dihydro-3H-dibenzisoquinoline-1,3-dione anticancer agents

Also Published As

Publication number Publication date
ES2229272T3 (es) 2005-04-16
MX9709254A (es) 1998-03-31
CN1067686C (zh) 2001-06-27
AU703111B2 (en) 1999-03-18
DE69634004D1 (de) 2005-01-13
EP0831094B1 (en) 2004-12-08
NO975493L (no) 1998-01-29
US5952335A (en) 1999-09-14
ATE284401T1 (de) 2004-12-15
EP0831094A4 (en) 2001-11-21
NO310149B1 (no) 2001-05-28
AU5845496A (en) 1996-12-18
KR19990022186A (ko) 1999-03-25
HUP9802672A2 (hu) 1999-04-28
CN1185781A (zh) 1998-06-24
EP0831094A1 (en) 1998-03-25
KR100399704B1 (ko) 2003-12-18
NO975493D0 (no) 1997-11-28
DE69634004T2 (de) 2005-11-10
NZ308657A (en) 1999-10-28

Similar Documents

Publication Publication Date Title
HUP9602122A2 (en) Camptothecin derivatives, process for the preparation thereof and pharmaceutical compositions containing them
IL117598A (en) Quinazoline derivatives, process for their preparation and pharmaceutical compositions containing them
HUP9700358A3 (en) New oxazolidinon derivatives, process for their preparation and pharmaceutical compositions containing them
AU4821096A (en) Benzazepine-, benzoxazepine- and benzothiazepine-N-acetic derivatives, process for their preparation and pharmaceutical compositions containing them
HUP9802200A3 (en) Rapamycin derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP9904680A3 (en) Thienopyrimidine derivatives, pharmaceutical compositions containing them and process for their preparation
HUP9603495A3 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation
HUP9802300A3 (en) N-heteroaryl-pyridinesulfonamide derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP9603494A3 (en) Hydroxycarboxamide derivatives, pharmaceutical compositions containing them, process for the preparation thereof
HUP0000562A3 (en) Fused pyrazole derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP9802565A3 (en) N-benzyl-dioxothiazolidinylmethyl-benzamide derivatives, pharmaceutical compositions containing them and process for producing the same
ZA968945B (en) 1,3-Dihydro-indol-2-one derivatives process for their preparation and the pharmaceutical compositions containing them
HUP9602511A2 (en) Aryl-diazinone derivatives, pharmaceutical compositions containing them, and process for producing all these
HUP0001555A3 (en) Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
AU6362796A (en) Substituted 4-phenylaminothiazoles, their process for preparation and the pharmaceutical compositions containing them
HUP9901613A3 (en) Substituted tetracyclic fused furanamine derivatives, process for their preparation, use thereof and pharmaceutical compositions containing them
HUP9600071A3 (en) Indolo-piperidine derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP9702400A3 (en) Substituted camptothecin derivatives, process for their preparation and pharmaceutical compositions containing them
HUP9602635A3 (en) 4-aciloxy-benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them
HUP9602681A1 (en) Hydroxy-pyridinone derivatives, process for producing them and pharmaceutical compositions containing them
HUP9600876A3 (en) Benzonitril- and -fluoride derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP9901739A3 (en) Aminoisoquinolines and aminothienopyridine derivatives, process for producing thereof and pharmaceutical compositions containing them
HUP9800466A3 (en) N-acyl-thieno[3,2-b]azepine derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0002300A3 (en) Quinoline-4-carboxamide derivatives, process for producing them, pharmaceutical compositions containing them and their use
HUP9901485A2 (en) Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use